EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus types

Maryam Ehsasatvatan iD, Bahram Baghban Kohnehrouz iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0311351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Maryam Ehsasatvatan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plant Breeding & Biotechnology, Faculty of Agriculture, University of Tabriz, Tabriz, Iran. Hauptthemen laut MEDLINE: Papillomavirus Vaccines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Iran National Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human papillomavirus (HPV), which is transmitted through sexual activity, is the primary cause of cervical cancer and the fourth most common type of cancer in women. In this study, an immunoinformatics approach was employed to predict immunodominant epitopes from a diverse array of antigens with the ultimate objective of designing a potent multiepitope vaccine against multiple HPV types. Immunodominant B cell, cytotoxic T cell (CTL), and helper T cell (HTL) epitopes were predicted using bioinformatics tools These epitopes were subsequently analyzed using various immunoinformatics tools, and those that exhibited high antigenicity, immunogenicity, non-allergenicity, non-toxicity, and excellent conservation were selected. The selected epitopes were linked with appropriate linkers and adjuvants to formulate a broad-spectrum multiepitope vaccine candidate against HPV. The stability of the multiepitope vaccine candidate was confirmed through structural analysis, and docking results indicated a high affinity for Toll-like receptors (TLR2 and TLR4). Molecular dynamics simulations demonstrated a persistent interaction of TLR2 and TLR4 with the multiepitope vaccine candidate. In silico immunological simulations showed that three injections of the multiepitope vaccine candidate resulted in high levels of B- and T-cell immune responses. Moreover, the in silico cloning results indicated that the multiepitope vaccine candidate could be expressed in substantial amounts in E . coli . The results of this study imply that designing a broad-spectrum vaccine against various HPV types using computational methods is plausible; however, experimental validation and safety testing to confirm the findings is essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Papillomavirus VaccinesHumansFemaleEpitopes, T-LymphocytePapillomavirus InfectionsPapillomaviridaeToll-Like Receptor 2Toll-Like Receptor 4T-Lymphocytes, CytotoxicMolecular Docking SimulationMolecular Dynamics SimulationEpitopes, B-LymphocyteEpitopesImmunodominant EpitopesHuman Papillomavirus Viruses

Substanzen

Papillomavirus VaccinesEpitopes, T-LymphocyteToll-Like Receptor 2Toll-Like Receptor 4Epitopes, B-LymphocyteEpitopesImmunodominant EpitopesTLR2 protein, human

Autor:innen und Institutionen

  • Department of Plant Breeding & Biotechnology, Faculty of Agriculture, University of Tabriz, Tabriz, Iran.

ORCID-Profile: Maryam Ehsasatvatan, Bahram Baghban Kohnehrouz

Förderung

  • Iran National Science Foundation

Zitieren

APA

Ehsasatvatan, M., & Baghban Kohnehrouz, B. (2024). Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus types. PLOS ONE. https://doi.org/10.1371/journal.pone.0311351

Vancouver

Ehsasatvatan M, Baghban Kohnehrouz B. Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus types. PLOS ONE. 2024. doi:10.1371/journal.pone.0311351

BibTeX
@article{Ehsasatvatan2024,
  author = {Ehsasatvatan, Maryam and Baghban Kohnehrouz, Bahram},
  title = {Designing and immunomolecular analysis of a new broad-spectrum multiepitope vaccine against divergent human papillomavirus types},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0311351}
}
Kostenlos starten →